Key Insights

Highlights

Success Rate

99% trial completion (above average)

Published Results

28 trials with published results (38%)

Research Maturity

67 completed trials (91% of total)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

1.4%

1 terminated out of 74 trials

Success Rate

98.5%

+12.0% vs benchmark

Late-Stage Pipeline

66%

49 trials in Phase 3/4

Results Transparency

42%

28 of 67 completed with results

Key Signals

28 with results99% success

Data Visualizations

Phase Distribution

66Total
Not Applicable (5)
P 1 (7)
P 2 (5)
P 3 (35)
P 4 (14)

Trial Status

Completed67
Unknown3
Withdrawn2
Terminated1
Not Yet Recruiting1

Trial Success Rate

98.5%

Benchmark: 86.5%

Based on 67 completed trials

Clinical Trials (74)

Showing 20 of 20 trials
NCT07380178Not ApplicableCompletedPrimary

The Effect of Apple Fruit Extract (Malus Sylvestris Mill) as an Antioxidant and Anti-Inflammatory on Allergic Rhinitis

NCT06577077Phase 3Not Yet RecruitingPrimary

Efficacy/ Safety of Product CM9241GRU in Patients With Perennial Allergic Rhinitis

NCT00779740Phase 3CompletedPrimary

Equivalency Study of Two Formulations of Mometasone Furoate Nasal Spray (Study P04419)

NCT00779545Phase 2CompletedPrimary

A Study of Mometasone Furoate Nasal Spray in Perennial Allergic Rhinitis (Study P03748)(COMPLETED)

NCT00092105Phase 3Completed

Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256)

NCT01135134Phase 3CompletedPrimary

Multicenter, Double-blind, Randomized, Placebo-controlled Study of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06332)

NCT01165424Phase 3CompletedPrimary

A Study of Long-term Administration of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06333AM1)

NCT00406783Phase 3Completed

Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683)

NCT00160680Phase 4CompletedPrimary

ATAREAL (Antihistamine Treatment for Allergic Rhinitis in Real Life)

NCT00761527Completed

Observation of Side Effects and Effectiveness of Desloratadine (Aerius) Syrup in Filipino Children (Study P05634)

NCT00092118Phase 3CompletedPrimary

The Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis (0476-265)

NCT00988247Phase 3CompletedPrimary

Long Term Safety and Efficacy Trial of Beclomethasone Dipropionate - Hydrofluoroalkane (BDP-HFA) 320 mcg in Allergic Rhinitis

NCT02443805Phase 3CompletedPrimary

Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR

NCT02972866Phase 3WithdrawnPrimary

Clinical Study, Non Inferiority Between Noex® 32µg Versus Budecort Aqua® 32µg in Treatment of Alergic Rhinitis

NCT02988778Phase 3WithdrawnPrimary

Clinical Study, Non Inferiority Between Noex® 50µg Versus Busonid® 50µg in Treatment of Allergic Rhinitis

NCT01115595Phase 4CompletedPrimary

Efficacy of Allergen Immunotherapy for Allergic Rhinitis in Thais

NCT03286049Completed

Short and Mid-term Repeatability of Active Anterior Rhinomanometry (AAR) Measurements in Paediatric Age

NCT02682745Phase 1CompletedPrimary

Single Dosing Clinical Trial of HL151

NCT02686294Phase 1CompletedPrimary

Repeated Dosing Clinical Trial of HL151

NCT02339714Phase 2CompletedPrimary

Effectivness and Safety of Acupuncture Combined With Moxibustion for Allergic Rhinitis

Scroll to load more

Research Network

Activity Timeline